CE
Bristol-Myers Squibb Company Ce
CELG-RI · NYSE
$0.11 -16.74% (-$0.02)
1M +13.76%
Market Cap $224.7M
P/E Ratio 0.03x
Div. Yield -
ROE 25.85%
Bulios Fair Price
$0.11
4.3% downside
Trenutna cena
$0.11
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CELG-RI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
100 /100
Cheap P/B 0.00x
P/E 0.03x
P/FCF 0.01x
Growth
79 /100
Growing FCF growth 18.22%
EPS growth 13.64%
Book val. growth 15.56%
Profitability
95 /100
Strong Op. margin 23.83%
Gross margin 48.71%
FCF margin 31.75%
Quality
100 /100
Excellent ROA 66.09%
ROIC 81.38%
Asset turnover 4.52x
Debt
46 /100
Moderate Int. coverage 4.93x
Debt/Equity -0.81x
Net debt/EBITDA -4.46x
Stability
19 /100
Unstable EPS volatility 240.26%
Beta -0.47x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CELG-RI
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Christopher S. Boerner
Employees
34,100
Headquarters
Princeton
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report